相关实验视频

Updated: Jun 14, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

针对前列腺癌的mRNA疫苗:一种新的有前途的免疫疗法

Yaxiong Tang¹, Xianyanling Yi¹, Jianzhong Ai¹

¹Department of Urology, Institute of Urology, West China Hospital, Sichuan University, 88 South Keyuan Road, Chengdu 610041, China.

Biochimica et biophysica acta. Reviews on cancer

|April 27, 2025

概括

晚期前列腺癌 (PCa) 通常会对标准治疗产生抗性. 使者RNA (mRNA) 疫苗由于其独特的优势,显示出作为割抵抗性前列腺癌 (CRPC) 的新免疫治疗策略的前景.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
疫苗技术技术疫苗技术

背景情况:

先进的前列腺癌 (PCa) 治疗依赖于雄激素剥夺疗法 (ADT),但导致割抵抗性前列腺癌 (CRPC) 的抵抗是不可避免的.
目前的CRPC治疗方法,包括新型内分泌药物,面临最终的耐药性,突出显示了对替代治疗策略的需求.
针对PCa的常规癌症疫苗在改善患者存活率方面表现出有限的成功.

研究的目的:

探索信使RNA (mRNA) 疫苗作为晚期前列腺癌,特别是CRPC新型治疗策略的潜力.
评估mRNA疫苗技术在前列腺癌治疗的优势.

主要方法:

审查前列腺癌治疗现有文献,包括ADT和CRPC疗法.
对PCa常规治疗癌症疫苗的开发和结果的分析.
检查mRNA疫苗的特征和有效性,并从其在其他领域 (例如COVID-19) 的成功中进行比较.

主要成果:

西普鲁塞尔-T是唯一一种常规的PCa疫苗,在转移性CRPC (mCRPC) 患者中显示出生存益处.
与传统疫苗相比,mRNA疫苗具有显著的优势,包括高效的生产,成本效益,安全性,强大的免疫性和适应性.
这些属性将mRNA疫苗定位为高级PCa的非常有前途的方法.

结论:

目前治疗晚期前列腺癌的局限性需要探索新的治疗方式.
使者RNA (mRNA) 疫苗技术为开发针对晚期前列腺癌的有效免疫疗法提供了一个有希望的前沿.
mRNA疫苗的独特优势为克服CRPC治疗耐药性的潜在突破提供了机会.

关键词:

癌症疫苗疫苗癌症疫苗免疫子类型免疫子类型免疫治疗是一种免疫疗法.前列腺癌是什么意思前列腺癌是什么意思这是mRNA疫苗.

更多相关视频

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.